Clinical Perspective

The unique additive feature of ROKEPIE®-FD01 allows a wide range of applications in the field of cell and tissue engineering. Additionally, ROKEPIE®-FD01 can be used in a clinical application as an excipient, for example the hypothermic storage of transplantation organs.

The active ingredient of ROKEPIE®-FD01 is a member of the SUL-compounds, which is a group of structurally-related compounds developed by Sulfateq. These compounds have a wide therapeutic range, currently one of the SUL-compounds is in a drug development trajectory. Sulfateq is constructing a Drug Master File (DMF) for their SUL-compounds, which is mandatory for compounds with an intended clinical use.

If you are exploring the possibility of using ROKEPIE® as excipient in your clinical application, please contact us. We are always interested in new application of our products. We will discuss the options with you and can share detailed information under confidentiality.

Please fill in our contact form for more information:

 

ROKEPIE is part of Sulfateq BV

Admiraal de Ruyterlaan 5
9726GN Groningen
The Netherlands

info@rokepie.com
+31(0)503137464

VAT number: NL823213730B01
Chamber of Commerce: 51293277